Trustees of Columbia University in the City of New York’s Kymera Therapeutics KYMR Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-278,127	Closed	-$13.5M	–	18
2021 Q2	$13.5M	Sell	278,127 -35,000	-11%	-$1.52M	19.92%	2
2021 Q1	$12.2M	Sell	313,127 -150,171	-32%	-$9.04M	14.75%	3
2020 Q4	$28.7M	Buy	+463,298	New	+$22.6M	38.38%	1

Other funds holding KYMR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Trustees of Columbia University in the City of New York's KYMR Position: Q3 2021 in Review

Trustees of Columbia University in the City of New York sold out of Kymera Therapeutics (KYMR) in Q3 2021, closing a stake of 278,127 shares — an estimated $13.5M sold.

Trustees of Columbia University in the City of New York first reported a position in KYMR in Q4 2020 and held it in 3 quarters. The position peaked at $28.7M in Q4 2020. 115 funds tracked by Wall St. Rank hold KYMR as of Q3 2021.

Trustees of Columbia University in the City of New York reported no remaining Kymera Therapeutics position as of Q3 2021 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 278,127 Kymera Therapeutics shares in Q3 2021, an estimated $13.5M.
Trustees of Columbia University in the City of New York first reported a position in Kymera Therapeutics in Q4 2020 and held it in 3 quarters.
Trustees of Columbia University in the City of New York's Kymera Therapeutics position peaked at $28.7M in Q4 2020.
115 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2021.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q3 2021, filed 15 Nov 2021.